Dan Abrams has signed off Dan Abrams Live for a final time. After announcing in December that he would be ending his weeknight primetime show for NewsNation, which he’d hosted since 2021, the veteran ...

NewsNation host Dan Abrams signed off for the last time on his show and said goodbye to both viewers and fellow host Ashleigh ...

NewsNation hosts Dan Abrams and Ashleigh Banfield reminisced about their enduring 25-year friendship, tracing it back to their romantic beginnings. Abrams hosted the final episode of his show Dan ...

Mediaite founder Dan Abrams accused NBC of “lying” about Chuck Todd’s departure from Meet the Press and replacing him with Kristen Welker on his SiriusXM show Monday, arguing that Todd was ...

Elizabeth Vargas has renewed her multiyear deal as her show moves to 7 p.m. By Etan Vlessing Canada Bureau Chief Former Fox New Channel host Leland Vittert has been tapped by NewsNation to replace ...

In December 2024, Dan Abrams announced that he would conclude his three-year run as the host of Dan Abrams Live on Nexstar Media Group’s NewsNation MVPD-distributed news and political commentary ...

NewsNation is shaking up its primetime lineup in the wake of Dan Abrams’ departure. Beginning Monday, Feb. 10, Leland Vittert’s “On Balance” will air in the 9 p.m. ET hour, while ...

Philadelphia Councilman Anthony Phillips says a small plane that crashed in Philadelphia landed on a "highly used roadway." Residents who were shopping at a nearby mall said it "felt like an ...

MassMutual High Yield Fund earns an Average Process Pillar rating. The main contributor to the rating is the fund's strong long-term risk-adjusted performance. This can be seen in its ten-year ...

MassMutual Small Cap Growth Eq Fd earns an Average Process Pillar rating. The leading factor in the rating is the fund's impressive long-term risk-adjusted performance. This can be seen in its ...

Are you a print subscriber? Activate your account. By Jack Neff - 12 min 4 sec ago By Erika Wheless - 1 hour 12 min ago By Pete Blackshaw - 4 hours 42 min ago By Gillian Follett - 4 hours 42 min ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. The new development is ...